Table 1.
Author (Year) | Design | Inclusion criteria | n (% male) | Mean/median age | Duration | Mortality |
---|---|---|---|---|---|---|
Continuous Renal Replacement Therapy (CRRT) versus Peritoneal Dialysis (PD) | ||||||
Al-Hwiesh et al. [27] (2018) |
RCT | • AKI requiring KRT |
CRRT = 62 (72.6%) PD = 63 (74.6%) |
CRRT = 44.6 ± 12.4 PD = 45.4 ± 4.1 |
28 days |
CRRT = 53.2% PD = 30.2% |
George et al. [28] (2011) |
RCT |
• AKI • No history of abdominal surgery • No pulmonary edema |
CRRT = 25 (60%) PD = 25 (64%) |
CRRT = 45.3 ± 17.5 PD = 45.3 ± 17.5 |
3 years |
CRRT = 84% PD = 72% |
Jaryal et al. [29] (2017) |
R-Obs |
• > 12 years • GFR < 60 ml/min/1.73m2 |
CRRT = 22 (50%) PD = 18 (66.7%) |
CRRT = 55.5 ± 19 PD = 51.1 ± 16 |
1 year |
CRRT = 81.8% PD = 77.8% |
Phu et al. [30] (2002) |
RCT |
• > 15 years • AKI requiring KRT |
CRRT = 34 (88%) PD = 36 (75%) |
CRRT = 35 (29.5–38.2) PD = 36 (29.6–38.4) |
1 year |
CRRT = 15% PD = 47% |
Peritoneal Dialysis (PD) versus Hemodialysis (HD) | ||||||
Basu et al. [31] (2016) |
R-Obs |
• 1 month to 16 years • Uremia, oliguria, anuria, and severe metabolic acidosis • Non-responsive fluid overload, • Persistent hyponatremia |
PD = 84 (51%) HD = 52 (67%) |
PD = 3.2 (0.1–7.6) HD = 8.4 (3.2–15.6) |
30 days |
PD = 39.3% HD = 66.3% |
Fenton et al. [32] (1997) |
R-Obs |
• ESRD • No history of dialysis or kidney transplant |
PD = 2841 (NR) HD = 7792 (NR) |
NR | 5 years |
PD = 26.2% HD = 30.9% |
Gabriel et al. [33] (2008) |
RCT | • With acute tubular necrosis |
PD = 60 (72%) HD = 60 (66%) |
PD = 62.5 ± 21.2 HD = 64.2 ± 19.8 |
60 days |
PD = 58% HD = 53% |
Murphy et al. [34] (2000) |
P-Obs | • Patients with renal failure of any kind |
PD = 282 (59.9%) HD = 540 (58.7%) |
PD = 56.1 (54.2–58.0) HD = 59.4 (58.1–60.7) |
6 months |
PD = 33.8% HD = 39.8% |
He et al. [35] (2020) |
R-Obs | • Patient with ESRD |
PD = 501 (58%) HD = 436 (53.9%) |
PD = 51.69 ± 14.47 HD = 57.11 ± 15.92 |
5 years |
PD = 4% HD = 21% |
Liem et al. [36] (2007) |
R-Obs |
• > 18 years • Requiring > 30 days KRT |
PD = 5802 (61.3%) HD = 10,841 (57.5%) |
PD = 53.6 ± 15 HD = 61.8 ± 14.6 |
6 months | Hazard ratio (PD vs. HD) = 0.70 (95% CI 0.67–0.74) |
Hemodialysis (HD) versus Continuous Renal Replacement Therapy (CRRT) | ||||||
Gaudry et al. [15] (2022) |
RCT | • AKI requiring KRT |
HD = 274 (63.9%) CRRT = 269 (62.4%) |
HD = 66.8 ± 13.3 CRRT = 66.2 ± 13.4 |
60 days |
HD = 46.3% CRRT = 54.3% |
Liang et al. [37] (2016) |
R-Obs |
• No history of chronic kidney dialysis, transplant, or heart failure • Creatinine level < 4 mg/dl |
HD = 353 (57.5%) CRRT = 285 (58.6%) |
NR | 90 days |
HD = 55.9% CRRT = 60% |
Schefold et al. [38] (2014) |
RCT |
• > 18 years • AFR requiring KRT |
HD = 128 (63.3%) CRRT = 122 (61.5%) |
HD = 60.8 ± 13.4 CRRT = 62.3 ± 14.5 |
30 days |
HD = 52.4% CRRT = 45.4% |
Truche et al. [39] (2016) |
P-Obs |
• Patients who received MV for ≥ 48 h in an ICU setting • No history of kidney transplant, CKD requiring KRT, or heart disease |
HD = 816 (65%) CRRT = 544 (63.6%) |
HD = 66.4 (54.8–76.1) CCRT = 64.3 (52.4–74.3) |
30 days |
CRRT = 46.5% HD = 35% |
Yilmaz Aydin et al. [40] (2022) |
P-Obs |
• AKI requiring KRT • No history of CKD or ESRD |
HD = 80 (38.7%) CRRT = 40 (37.5%) |
HD = 61.4 ± 15.2 CRRT = 65.9 ± 9.1 |
30 days |
HD = 66.3% CRRT = 67.5% |
AKI acute kidney injury, ARF Acute renal failure, ESRD end-stage renal disease, GFR glomerular filtration rate, KRT renal replacement therapy, MV mechanical ventilation, NR not reported, P-Obs prospective observational study, R-Obs retrospective observational study